Gastroparesis Market Forecast 2026–2035: Data Trends and Industry Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the gastroparesis market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Gastroparesis Market between 2026 and 2030?

The gastroparesis market has experienced robust expansion in recent years. Projections indicate it will increase from $7.15 billion in 2025 to $7.52 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.1%. Historically, this market’s expansion can be linked to factors like diabetes-related gastric disorders, the application of antiemetic medications, specialized hospital-based GI care, various dietary management strategies, and the prevalence of diagnostic imaging.

The gastroparesis market is set to experience substantial growth in the coming years. It is forecast to reach $9.29 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.5%. This expansion during the forecast period can be attributed to innovations in implantable stimulation devices, the rise of outpatient treatment models, an increasing diabetic population, the demand for symptom-focused therapies, and improved clinical awareness. Key trends anticipated during this period include a heightened use of prokinetic medications, the growing adoption of gastric electrical stimulation devices, an increased focus on dietary and lifestyle management, the availability of more minimally invasive surgical options, and enhanced diagnosis of diabetic gastroparesis.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Drivers Are Expected To Impact The Gastroparesis Market During The Forecast Period?

The gastroparesis market is expected to expand moving forward due to the escalating prevalence of diabetes. Diabetes is a chronic medical condition defined by elevated blood glucose levels, resulting from the body’s insufficient insulin production or its inability to use insulin effectively. The widespread occurrence of diabetes substantially raises the probability of developing gastroparesis, as diabetes plays a crucial role in enlarging the population susceptible to this ailment. For example, in April 2025, the International Diabetes Federation, a Belgium-based advocacy organization, reported that globally, nearly one in nine adults (589 million) are currently living with diabetes. Of these, an estimated 252 million are unaware they have the condition, which puts them at higher risk of serious complications and early death. Consequently, the rapid surge in the prevalence of diabetes is driving the gastroparesis market.

How Is The Gastroparesis Market Divided Into Segments?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

How Are New Market Trends Shaping The Landscape Of The Gastroparesis Market?

Leading companies in the gastroparesis market are actively developing pharmaceuticals to boost their profitability. Drugs utilized for treating gastroparesis serve diverse functions to manage symptoms associated with delayed stomach emptying. For instance, in December 2023, Vanda Pharmaceuticals Inc., a US-based biopharmaceutical company, announced that the U.S. FDA had accepted the New Drug Application for Tradipitant, indicating a promising step towards its potential approval for gastroparesis treatment. The FDA has established September 18, 2024, as the decision date for Tradipitant under the Prescription Drug User Fee Act (PDUFA). If successful, Tradipitant would be the first FDA-approved novel drug for gastroparesis in over 40 years, representing a significant milestone as it would be the first drug to undergo specific FDA review for gastroparesis in more than three decades.

Which Leading Companies Dominate The Gastroparesis Market Share?

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastroparesis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2026, By The Business Research Company

Gastric Volvulus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Gastroparesis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report

Diabetic Gastroparesis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795